CAPTRUST Financial Advisors
AXSM icon

CAPTRUST Financial Advisors’s Axsome Therapeutics AXSM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
10,352
-1,214
-10% -$263K ﹤0.01% 1171
2026
Q1 		$1.95M Buy
11,566
+322
+3% +$55.6K ﹤0.01% 1236
2025
Q4 		$2.05M Buy
11,244
+3,285
+41% +$459K ﹤0.01% 1083
2025
Q3 		$967K Buy
7,959
+967
+14% +$109K ﹤0.01% 1447
2025
Q2 		$730K Buy
6,992
+3,888
+125% +$412K ﹤0.01% 1507
2025
Q1 		$362K Buy
3,104
+151
+5% +$17.2K ﹤0.01% 1837
2024
Q4 		$250K Sell
2,953
-2,769
-48% -$255K ﹤0.01% 2017
2024
Q3 		$514K Buy
+5,722
New +$499K ﹤0.01% 1559
2023
Q4 		– Sell
-2,881
Closed -$201K – 2671
2023
Q3 		$201K Buy
2,881
+30
+1% +$2.24K ﹤0.01% 2292
2023
Q2 		$205K Buy
+2,851
New +$210K ﹤0.01% 2251
2022
Q3 		– Sell
-705
Closed -$27K – 2236
2022
Q2 		$27K Sell
705
-52
-7% -$1.65K ﹤0.01% 3186
2022
Q1 		$31K Buy
757
+646
+582% +$20K ﹤0.01% 3114
2021
Q4 		$4K Buy
111
+35
+46% +$1.29K ﹤0.01% 4158
2021
Q3 		$3K Buy
76
+16
+27% +$624 ﹤0.01% 4112
2021
Q2 		$4K Hold
60
– – ﹤0.01% 3936
2021
Q1 		$3K Hold
60
– – ﹤0.01% 3889
2020
Q4 		$5K Hold
60
– – ﹤0.01% 2827
2020
Q3 		$4K Buy
+60
New +$4.67K ﹤0.01% 2575
2020
Q2 		– Sell
-3,400
Closed -$190K – 2844
2020
Q1 		$190K Sell
3,400
-250
-7% -$20.4K ﹤0.01% 873
2019
Q4 		$370K Buy
+3,650
New +$147K 0.01% 782

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CAPTRUST Financial Advisors's AXSM Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Axsome Therapeutics (AXSM) stake by 10% in Q2 2026, selling an estimated $263K and leaving 10,352 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1171.

CAPTRUST Financial Advisors first reported a position in AXSM in Q4 2019 and has held it in 20 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • CAPTRUST Financial Advisors held 10,352 shares of Axsome Therapeutics worth $2.53M as of Q2 2026.
  • CAPTRUST Financial Advisors sold 1,214 Axsome Therapeutics shares in Q2 2026, an estimated $263K.
  • Axsome Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1171 holding.
  • CAPTRUST Financial Advisors first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 20 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.